Oaktree Acquisition Corp. III Life Sciences
OACC
$10.60
$0.020.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.38% | -39.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.38% | -39.34% | |||
| Operating Income | 16.38% | 39.34% | |||
| Income Before Tax | 4.93% | 12.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.93% | 12.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.93% | 12.99% | |||
| EBIT | 16.38% | 39.34% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 4.99% | 12.89% | |||
| Normalized Basic EPS | 4.82% | 13.03% | |||
| EPS Diluted | 4.99% | 12.89% | |||
| Normalized Diluted EPS | 4.82% | 13.03% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||